AtriCure
ATRC
86 hedge funds and large institutions have $293M invested in AtriCure in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 10 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
78% more capital invested
Capital invested by funds: $165M → $293M (+$128M)
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
9% more funds holding
Funds holding: 79 → 86 (+7)
36% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.92M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.92M |
| 3 |
Millennium Management
New York
|
+$2.54M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.12M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$4.63M |
| 2 |
BC
Broadfin Capital
New York
|
-$3.49M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.64M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.37M |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$2.23M |
ATRC Hedge Fund Activity: Q4 2013 in Review
86 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2013, worth a combined $293M — up 78% from $165M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ATRC positions and 10 closed out — a net gain of 7 holders — while 23 added to existing stakes and 36 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.92M. The largest seller was Kopp Investment Advisors, cutting an estimated $4.63M.
- 86 institutional investors held AtriCure (ATRC) as of Q4 2013, up from 79 in Q3 2013.
- Funds reported $293M of AtriCure stock for Q4 2013, up 78% quarter-over-quarter.
- 17 funds opened new AtriCure positions in Q4 2013 and 10 closed out, a net change of +7 holders.
- The largest AtriCure buyer in Q4 2013 was Fidelity Investments, an estimated $4.92M added.
- The largest AtriCure seller in Q4 2013 was Kopp Investment Advisors, an estimated $4.63M sold.
Based on aggregated 13F filings for Q4 2013.